Teriparatide
- Generic Name
- Teriparatide
- Brand Names
- Forsteo, Forteo, Movymia, Kauliv, Sondelbay, Teriparatide Sun, Terrosa, Livogiva
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 52232-67-4
- Unique Ingredient Identifier
- 10T9CSU89I
- Background
Teriparatide is a recombinant parathyroid hormone (PTH) analog and a potent osteoanabolic agent. It is made up of the first amino(N)-terminal 34 amino acids of the human PTH. First approved in the United States in November 2002 and in Europe in April 2003, teriparatide makes the first approved drug in a new category of osteoporosis therapy called anabolic th...
- Indication
Teriparatide is indicated:
- Associated Conditions
- Osteoporosis, Osteoporosis caused by Glucocorticoid Treatment, Primary Osteoporosis
- Associated Therapies
- -
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
- Conditions
- Interventions
- First Posted Date
- 2010-10-20
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- Thomas J. Schnitzer
- Target Recruit Count
- 60
- Registration Number
- NCT01225055
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Edward Hines, Jr, VA Hospital, Maywood, Illinois, United States
The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures
- First Posted Date
- 2010-07-30
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Ohio Orthopedic Center of Excellence
- Target Recruit Count
- 38
- Registration Number
- NCT01173081
- Locations
- 🇺🇸
Ohio Orthopedic Center of Excellence, Upper Arlington, Ohio, United States
Teriparatide for Postsurgical Hypoparathyroidism
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2014-12-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5
- Registration Number
- NCT01171690
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2014-09-22
- Lead Sponsor
- University of Wisconsin, Madison
- Target Recruit Count
- 26
- Registration Number
- NCT01166958
- Locations
- 🇺🇸
University of Wisconsin Osteoporosis Clinical Center and Research Program, Madison, Wisconsin, United States
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 100
- Registration Number
- NCT01155232
- Locations
- 🇨🇦
University Health Network, TGH, Toronto, Ontario, Canada
Teriparatide (PTH) and Bone Strength in Postmenopausal Women
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 60
- Registration Number
- NCT01155245
- Locations
- 🇨🇦
University Health Network, TGH, Toronto, Ontario, Canada
µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis
- Conditions
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 33
- Registration Number
- NCT01153425
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Does Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?
- First Posted Date
- 2010-04-19
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- University Hospital, Linkoeping
- Target Recruit Count
- 40
- Registration Number
- NCT01105832
- Locations
- 🇸🇪
Lasarettet i Motala, Motala, Sweden
🇸🇪Department of Orthopaedics, Norrköping, Sweden
Study of FORTEO Use in Subjects in the Community Setting
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 4167
- Registration Number
- NCT01078805
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lakewood, Colorado, United States
Teriparatide for Improved Knee Prosthesis Fixation
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- University Hospital, Linkoeping
- Target Recruit Count
- 60
- Registration Number
- NCT01063504
- Locations
- 🇸🇪
Motala hospital, Motala, Sweden
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.